COCOS 4 Is Here, Fully Open Source

BEIJING, Jan. 5, 2026 /PRNewswire/ — COCOS, the globally renowned provider of…

Timekettle Announces 2026 Breakthroughs in AI Interpretation, Introducing Its State-of-the-Art Translation Engine Selector and Next-Generation Bone-Conduction Voice Capture

Flagship W4 Earbuds Become the Most Accurate Interpreter Device Ever Released LAS…

Meraas unveils Dubai Design District residential masterplan, introducing a world-class waterfront neighbourhood

DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ — Meraas, a member of Dubai…

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.…

Cango Inc. Announces December 2025 Bitcoin Production and Mining Operations Update

DALLAS, Jan. 5, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG) ("Cango" or…

Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program

DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange…

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram’s Premium Aesthetics…

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or…